Hyperlipoprotein(a) in patients with spondyloarthritis: results of the Cardiovascular in Rheumatology (CARMA) project.
Por:
García-Gómez MC, Martín-Martínez MA, Fernandez-Carballido, C, Castañeda S, González-Juanatey C, Sanchez-Alonso F, González-Fernández MJ, Sanmartí R, García-Vadillo JA, Fernández-Gutiérrez B, García-Arias M, Manero FJ, Senabre, J, Rueda-Cid A, Ros-Expósito S, Pina-Salvador JM, Erra-Durán A, Möller-Parera I, Llorca J, González-Gay MA and CARMA Project Collaborative Group
Ahead of Print:
15 feb 2019
Resumen:
Cardiovascular (CV) disease is one of the main causes of morbi-mortality in spondyloarthritis (SpA), partially explained by traditional CV risk factors. Information on lipoprotein(a) [Lp(a)], a non-conventional risk factor, in SpA is scarce. In this study we assessed the prevalence of hyperlipoproteinaemia(a) in SpA patients and analysed the possible related factors.
Filiaciones:
García-Gómez MC:
Division of Rheumatology, Consorci Sanitari de Terrassa, Barcelona, Spain
Martín-Martínez MA:
Research Unit of Spanish Society of Rheumatology, Madrid, Spain
:
Division of Rheumatology, Hospital U. de Elda, Alicante, Spain
Castañeda S:
Division of Rheumatology, Hospital U. de la Princesa, IIS-IP, Madrid, Spain
González-Juanatey C:
Division of Cardiology, Hospital U. Lucus Augusti, Lugo, Spain
Sanchez-Alonso F:
Research Unit of Spanish Society of Rheumatology, Madrid, Spain
González-Fernández MJ:
Division of Rheumatology, Hospital Universitari Dexeus, Barcelona, Spain
Sanmartí R:
Division of Rheumatology, Hospital Clínic i Provincial, Barcelona, Spain
García-Vadillo JA:
Division of Rheumatology, Hospital U. de la Princesa, IIS-IP, Madrid, Spain
Fernández-Gutiérrez B:
Division of Rheumatology, Hospital Clínico San Carlos, Madrid, Spain
García-Arias M:
Division of Rheumatology, Ponferrada, León, Spain
Manero FJ:
Division of Rheumatology, Hospital Miguel Servet, Zaragoza, Spain
Senabre, J:
Division of Rheumatology, Hospital Marina Baixa, La Vila Joiosa, Alicante, Spain
Rueda-Cid A:
Division of Rheumatology, Hospital General U. de Valencia, Spain
Ros-Expósito S:
Division of Rheumatology, Hospital de Viladecans, Barcelona, Spain
Pina-Salvador JM:
Division of Rheumatology, Hospital de Barbastro, Huesca, Spain
Erra-Durán A:
Division of Rheumatology, Hospital de Sant Rafael, Barcelona, Spain
Möller-Parera I:
Division of Rheumatology, Instituto Poal, Barcelona, Spain
Llorca J:
University of Cantabria, IDIVAL, Santander, Spain, and CIBER Epidemiologia y Salud Pública (CIBERESP), Spain
González-Gay MA:
Epidemiology, Genetics Atherosclerosis Res. Group on Systemic Inflammatory Diseases, Rheumatology Div., Hosp. Univ. Marqués de Valdecilla, IDIVAL, Univ. of Cantabria, Santander, Spain, and Univ. of the Witwatersrand, Johannesburg, South Africa
|